[Improve the benefit/risk balance of methadone by respecting its pharmacological specificities].

Améliorer la balance bénéfices/risques de la méthadone en respectant ses spécificités pharmacologiques.

Journal

Therapie
ISSN: 1958-5578
Titre abrégé: Therapie
Pays: France
ID NLM: 0420544

Informations de publication

Date de publication:
Jun 2019
Historique:
received: 27 08 2018
revised: 04 09 2018
accepted: 18 09 2018
entrez: 11 6 2019
pubmed: 11 6 2019
medline: 28 12 2019
Statut: ppublish

Résumé

Recent data on methadone from 2008 to 2017 by the French addictovigilance network warms on the increase of methadone use, its diversion, its increase of overdose risk factors (opioids associated, occasional use) and deaths. Whereas methadone is an essential drug for opioid addiction, its use remains complex because of its pharmacology leading to increase the awareness of health professionals.

Identifiants

pubmed: 31178032
pii: S0040-5957(18)30217-8
doi: 10.1016/j.therap.2018.09.070
pii:
doi:

Substances chimiques

Analgesics, Opioid 0
Methadone UC6VBE7V1Z

Types de publication

Journal Article

Langues

fre

Sous-ensembles de citation

IM

Pagination

383-388

Informations de copyright

Copyright © 2018 Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS. All rights reserved.

Auteurs

Elisabeth Frauger (E)

Inserm, service de pharmacologie clinique et pharmacovigilance, centre d'addictovigilance PACA-Corse, institut de neurosciences des systèmes, Aix-Marseille université, AP-HM, 13005, Marseille, France. Electronic address: elisabeth.frauger@ap-hm.fr.

Nathalie Fouilhé Sam-Laï (N)

Centre d'addictovigilance, CHU de Grenoble-Alpes, 38043 Grenoble, France.

Michel Mallaret (M)

Centre d'addictovigilance, CHU de Grenoble-Alpes, 38043 Grenoble, France.

Joëlle Micallef (J)

Inserm, service de pharmacologie clinique et pharmacovigilance, centre d'addictovigilance PACA-Corse, institut de neurosciences des systèmes, Aix-Marseille université, AP-HM, 13005, Marseille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH